Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan pushes FDA to defend Restasis from early generics
Allergan pushes FDA to defend Restasis from early generics
Allergan pushes FDA to defend Restasis from early generics
Submitted by
admin
on August 21, 2013 - 10:20am
Source:
Fierce Pharma
News Tags:
Allergan
Restasis
dry eye disease
FDA
generics
Headline:
Allergan pushes FDA to defend Restasis from early generics
Do Not Allow Advertisers to Use My Personal information
